Login / Signup

Medication-related osteonecrosis of the jaw incidence in patients exposed concomitantly to bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors: is it generalizable to all solid tumors?

Kadri Altundag
Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)
Keyphrases
  • vascular endothelial growth factor
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • healthcare
  • prognostic factors
  • risk factors
  • bone mineral density
  • patient reported outcomes